4C3498).
Introduction
The human a9 integrin subunit was only recently characterized at the molecular level (1). In the cell lines studied thus far, a9 forms heterodimers with the PI subunit. a9 is present in the stratified squamous epithelium of the skin in the cell membranes of the basal cell layer at sites of potential cell-cell and cell-substrate interaction (I), a localization pattern essentially identical to that reported for several other PI-family integrins including a2 and a3 (2-4).
New data show that the a901 integrin recognizes the third fibronectin Type I11 repeat of tenascin as a ligand ( 5 ) .
The present studies were initiated to determine whethx a9 is expressed in the stratified squamous epithelium of the cornea. In adult mouse, we found that although there is only a low level of expression of a9 in the basal cells of the central cornea, there is abundant expression of a9 in the basal cells of the limbus, the site at which the stem cells for the corneal epithelium are located. This distribution suggests a role for a9 integrin in epithelial cell differentiation. We studied the postnatal mouse cornea during the period from birth through eyelid opening, a period marked by the rapid stratification and differentiation of the cells that comprise the corneal epithelium. We found that a9 expression in the basal cells of the lid, conjunctiva, and cornea is regulated during postnatal corneal development, whereas a3 expression is not. Because tenas- cin is a ligand for a9D1, we also performed double-labeling experiments using a9 and tenascin antibodies. We found that tenascin expression is not correlated with that of a9 in the epithelium of the adult skin, cornea, or in the postnatal developing mouse cornea, suggesting that a9 recognizes ligands other than tenascin in these tissues.
Materials and Methods
Animal Model. Female Balbk mice were used for the generation of pups. The pups were examined at the day of birth (Day 1) and 5. 10, 14. and 21 days after birth. At Days 1, 5 . 10, and 14, no fewer than two pups per litter were sacrificed by decapitation and heads processed for immunohistochemistry. For adults and 21-day-old pups, animals were sacrificed by lethal injection of sodium pentobarbital, eyes removed. and corneas dissected.
Antibodies. A polyclonal antibody directed against the cytoplasmic domain of a0 integrin and affinity-purified against a peptide affinity column was used (1). Polyclonal antibodies against cytoplasmic domains of a , and 81 integrin have been described (6) and were obtained from the labora-tory of Richard 0. Hynes (Center for Cancer Research and the Howard Hughes Medical Institute, Masachuserrs Institute of Technology, Cambridge. MA). The monoclonal anti-mouse tenascin antibody was obtained from Sigma Immunochemical Company (T-3413; St Louis. MO).
Immunohistochemical Analysis. The dissected corneas and pup heads were frozen in Tissue Tek I1 OCT compound (Lab Tek: Naperville. IL). Cryostat sections (6-wm) were placed on poly-L-lysine-coated slides and dried overnight at 37'C. These slides were rehydrated in PBS and washed in PBS containing 1% (wlv) bovine serum albumin (BSA) (Sigma) and 1% horse serum (Sigma) for 10 min. The appropriate dilution of each primary anribody (1:100-1:1000) was then applied for 1 hr at room temperature (RT) in a moist chamber. The slides were rinsed with PBS. followed bv 10 min in PBS with 1% BSA and 1% horse serum, and the secondary antibody fluorescein-conjugated donkey anti-rabbit IgG (Amersham; Arlington Heights, IL), applied for 1 hr at RT in a moist chamber. After a PBS wash. coverslips were mounted with FITC-Guard (Testog; Chicago. IL), a fluorescence enhancer and glycerol-based mounting medium, and then sealed. with an Olympus VANOX ASHBS3 microscope. All photographs were taken with a x 20 objective and an exposure time of 15-30 sec. For double-labeling immunofluorescence, the slides were incubated simultaneously with primary antibodies from *rent species followed by species-specific secondary antibodies conjugated, respectively, to fluorescein and Texas red.
Confocal microscopy was performed in the Center for Microscopy and Image Analysis at GWU Medical Center. Sections labeled with both fluorescein and Texas red conjugate were sequentially analyzed at 488 nm and 567 nm wavelengths using a confocal Laser Scanning Microscope (Bio-Rad MRC 1000; Richmond, CA), with an argon ion laser operating in multiline mode. The typical z-series is composed of optical sections in the xy optical plane. These images are en face optical sections through the vertical axis of the tissue. Each image of the series was taken at 1-pm intervals with a x 20 (NA 1.4) objective. Images are presented in pseudocolor based on fluorochrome intensity, with white representing maximal brightness. Merged images were computer-generated from two optical sections in the same focal plane recorded from the fluorescein or Texas red photomultiplier tubes. The images were electronically colored so that the individual images were green and red. The combined image maintains the red and green color in pixels that do not overlap. Pixels that contain information from both images were colored yellow, indicating an overlap in the digital information.
Results
Mouse corneas were analyzed by immunofluorescence microscopy using polyclonal antibodies directed against the cytoplasmic domains of a9 and a3. A minor amount of a9 integrin was observed in the basal membranes of the basal cells of the central corneal epithelium, as shown in Figure IA . This distribution pattern was quite different from that seen in skin (Figure lB, inset), where a9 was abundant in the basal cell layer around the basal and lateral cell membranes. In the peripheral cornea, a9 was present in the cell membranes of the limbal epithelial basal cells and basal cells of the conjunctiva, with expression diminishing towards the central comea as shown in Figure 1B . In contrast, a3 was abundant in the basal and lateral membranes of the basal and suprabasal cells of the comeal epithelium ( Figure IC) and in the basal cells of the limbus and conjunctiva ( Figure ID) . a9 and a3 expression was analyzed in the postnatal mouse from birth to 21 days of age to determine when a9 becomes restricted to the limbus and to compare the localization of a9 to that of a3. Figures 2A-2C are schematic drawings presented to orient the reader. For postnatal Days 1, 5, 10, and 14, the lids are fused and data presented show either the central region (fused lids, central corneal epithelium, corneal stroma) or the region at which the epithelial tissue tums and changes from conjunctiva to peripheral corneal epithelium, the site where the conjunctival-limba1 border will be located in the adult cornea.
At birth ( Figure 3A ) the localization of a9 in the stratified squamous epithelium of the outer eyelid (straight arrow) was identical to that of adult skin (compare with Figure lB, inset). Where the eyelids were fused, a9 was absent in the basal cells but abundant in the membranes of suprabasal cells between the two lids. The basal cells of the central corneal epithelium lacked a9, but a9 was present on the basal cells of the developing conjunctiva, morphologically defined as the epithelium lining the inner eyelid ( Figure 3C ). Expression of a9 in the conjunctival basal cells appeared continuous to the site of the location of the future limbus, where the intensity of a9 staining decreased. a3 was found in the basal cell membranes where the lids are fused and in the basal cell membranes in the upper eyelid, central and peripheral corneal epithelium, and conjunctiva ( Figures 3B and 3D) . Analyses using antibodies directed against either the a2 or the pi subunit gave results similar to those shown for a3 (data not shown).
At Day 5 ( Figure 3E ) there was still abundant a9 in the suprabasal cells between the fused lids and in the conjunctiva. The basal cells located at the plane of lid fusion had become slightly positive for as. yet the basal cells of the central corneal epithelium still lacked a9 expression. a9 expression was beginning to turn on in peripheral corneal basal cells adjacent to the developing limbal-conjunctival border, seen as enhanced expression of a9 in the peripheral corneal basal cells relative to the basal cells of the conjunctiva ( Figure 3G ). a3 continued to be expressed in the basal cells of the fused eyelids and the basal cells of the central corneal epithelium, developing limbus, and conjunctiva ( Figures 3F and 3H) .
At Day 10 ( Figure 4A ) the location of the cleavage plane between the lids was clearly visible and a9 expression was apparent in the basal cells at this location. The suprabasal cells between the lids were becoming negative at the outer lid, whereas they were still positive at the inner eyelid near the conjunctival-tarsal border. The basal cells of the central cornea were positive for as, with the intensity of a9 expression increasing towards the periphery. a9 was expressed equally in the peripheral comeal epithelial basal cells and the basal cells of the conjunctiva at Day 10 ( Figure 4C ). a3 localization ( Figures 4B and 4D ) remained similar to that of earlier developmental stages. Figure 4E) . The cells between the lids were flat and squamous. In addition, the central corneal epithelial cells were almost entirely negative for ag, but a9 expression could still be detected in the peripheral region ( Figure 4G) . In contrast, a3 expression appeared not to vary significantly from the central corneal basal cells to the conjunctival basal cells (Figures 4F and 4H) .
By 21 days, the adult phenotype for a9 expression in the lid, limbus, and cornea was established ( Figures SA-5C ). The relative absence of a9 in the basal cells of the cornea sharply contrasted with the abundance of a3 in the same cell population (compare Figures 5A-5C with Figures SD-SE) .
To determine whether a9 and tenascin co-localize in the developing mouse cornea and eyelid, double-labeling immunofluorescence microscopy was performed using confocal microscopy; the results are presented in Figures 6A-6D . The confocal images for a9 (green) were quite similar to those shown using standard immunofluorescence microscopy in Figures 3-5 . However, the confocal microscope was able to detect a9 in central cornea as early as Day 5 . There also appeared to be more a9-positive suprabasal cells in the confocal images at Days 1 and 5. These differences are likely due to enhanced sensitivity of the confocal microscope or to variation among individuals at early times after birth. Tenascin (red) was prominently localized to the basement membrane underlying the basal cells at the site of lid fusion at all of the stages in which the lids remained fused. After the eyes opened, tenascin expression at this site was lost (data not shown). In addition, tenascin was not apparent in the basement membranes underlying either the limbus or conjunctiva (data not shown). Within the mesenchyme of the eyelid, tenascin was found around occasional vessels, hair follicles, and glands. However, in unfixed frozen sections it was impossible to resolve the identities of these tenascin-positive structures. Therefore, in the epithelial cells of the developing eyelid and cornea, the localizations of a9 and tenascin do not overlap.
Discussion
In the adult mouse, a9 is expressed predominantly in the limbus, with the amount of a9 decreasing dramatically at the peripheral cornea and continuing to decrease towards the central cornea. This profile of expression is also present in the rat cornea (7); in bovine and human corneas, there is a more gradual transition from a9positive cells to cells not expressing a g , such that expression in human corneas continues past the start of Bowman's membrane (data not shown).
Furthermore, at the time of birth in the mouse, a 9 localization in the fused eyelid is restricted to the basal cells of the outer lid and inner conjunctiva and to a suprabasal cell population between the fused lids. The two-cell-layer central corneal epithelium does not express detectable a9 at birth. Over time, the as-positive suprabasal cell population becomes progressively restricted to cells at the inner eyelid; during this time, the basal cell population at the site of lid fusion begins to express as. In the cells of the central corneal epithelium, a9 expression increases from birth to around Day 10. After Day 10, the as-positive basal cells of the central and peripheral cornea lose expression. Expression of a9 is retained only in the basal cells of the limbus, the conjunctiva, and the outer eyelid epidermis.
The data presented on the localization of a3 in the developing mouse cornea suggest that the changes in a 9 expression in the developing cornea and eyelid are specific to the a9 subunit. Therefore, these data suggest that a9 expression in epithelial cells is differentially regulated in the developing cornea. Furthermore, since in the developing eyelid and cornea the localizations of a9 and tenascin do not significantly overlap, the function(s) of a 9 in epithelial cell differentiation in the eyelid and cornea is(are) likely to involve additional, as yet to be described, ligands andlor counterreceptors.
The integrins are a large family of cell surface glycoproteins that function in mediating cell-substrate and cell-cell interactions (8) . A role for integrin-extracellular matrix interaction in the terminal differentiation of epidermal keratinocytes is now well documented by many in vitro studies (for review see 4 ) . In cultures of keratinocytes undergoing stratification and terminal differentiation, the movement of cells away from the basal cell layer is associated with loss of integrin function and expression (9.10). Interfering with terminal differentiation by placing cells in suspension culture or in low-calcium medium results in retention of integrin mRNAs and integrin proteins on cell surfaces that would normally be lost (9,ll). An epithelial cell line (HaCaT), that stratifies in vitro and synthesizes a$1, a3p1, and asp1 integrins and expresses them at regions of cell-cell contact, along with desmosomal markers and cadherins, was transfected with the MyoDl gene to determine the effects of epithelial to mesenchymal-myogenic transdifferentiation on expression of integrins, cadherins, and desmosomal markers (12) . The transfected cells lost much of their adhesive capacity, failed to straufy, and stopped expressing desmosomal markers and cadherins. In addition, after transfection only a& integrin expression was retained. All of these in vitro studies suggest an important role for integrins in maintenance of the epithelial cell phenotype and in epithelial cell terminal differentiation.
family of integrins, primarily a2 and a3, are expressed on the basal and lateral membranes of the basal cells of stratified squamous epithelia (2,1347). Conditions associated with rapid cell proliferation result in integrin production and expression in the suprabasal cell populations, as indicated by studies of both in vivo human wound healing (18, 19) and of the skin involved in inflammatory skin disorders such as psoriasis (20, 21) . A further role for integrins in epidermal differentiation is indicated by studies of integrin expression in developing human skin (22) and by studies of basal and squamous cell carcinomas and cell lines derived form carcinomas (23,24).
The corneal epithelium is another stratified squamous epithelium. Studies of the expression of integrins, not including the asp1 integrin, in the corneal epithelium have yet to show significant differences between the integrins expressed in cornea and those present in the skin (25-29). The similarities in expression and distribution of integrins between the skin and central cornea are interesting in that the cells within these epithelia differ markedly
In vivo, histological studies have shown that the a9 INTEGRIN AND EPITHELIAL DIFFERENTIATION in their proliferative properties. In the skin, stem cells are located at the centers of distinct groupings of cells, termed epidermal proliferative units (30,31) , which are located within the basal cell layer (32-34). In the cornea, the epithelial stem cell population is located in the basal cells of the limbus (35-38) , an epithelial cell population found between the peripheral cornea and the conjunctiva. If integrins are involved in the regulation of terminal differentiation in epithelia, one might expect to see some differences in the types and amounts of integrins present in the skin, central cornea, and limbus. Our studies show just such a difference.
Given the restricted localization of a9 to those epithelial cell populations that retain stem cell capacity and the regulated expression of a9 during the postnatal differentiation of the mouse cornea, we believe that the a9 integrin may be an important receptor helping to maintain a proliferative epithelial cell phenotype.
